Metraipolis › archive › dc_906357a2e15e

MicroRNAs as key regulators of cancer drug resistance: insights and future directions in chemotherapy, targeted-therapy, radiotherapy, and immunotherapy — Europe PMC PMID:41425255

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41425255
DOI
10.20517/cdr.2025.146
License (as archived)
solo-consultazione
Archived
2026-11-07T18:08:11.355Z
SHA-256 of the archived text
762e71962da3c37eff064e8df864f276f279eb3049093383b5858a54131f4de9
Stable URL of this page
https://metraipolis.com/documento/dc_906357a2e15e

How to cite

MicroRNAs as key regulators of cancer drug resistance: insights and future directions in chemotherapy, targeted-therapy, radiotherapy, and immunotherapy — Europe PMC PMID:41425255 — Europe PMC (en), https://europepmc.org/article/MED/41425255 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_906357a2e15e (Metraipolis archive dc_906357a2e15e, sha256 762e71962da3c37eff064e8df864f276f279eb3049093383b5858a54131f4de9)
BibTeX
@misc{dc906357a2e15e,
  title = {MicroRNAs as key regulators of cancer drug resistance: insights and future directions in chemotherapy, targeted-therapy, radiotherapy, and immunotherapy — Europe PMC PMID:41425255},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41425255},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_906357a2e15e; sha256 762e71962da3c37eff064e8df864f276f279eb3049093383b5858a54131f4de9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41425255. Agents can read the archived copy with the MCP tool read_document.